Nuveen Asset Management »

Regulus Therapeutics shares owned by Nuveen Asset Management

Quarter-by-quarter ownership of Regulus Therapeutics (RGLS) shares owned by Nuveen Asset Management from 13F filings

Historical chart of Nuveen Asset Management investment in Regulus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Regulus Therapeutics held by Nuveen Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regulus Therapeutics by Nuveen Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $153k 86k 1.79

More positions owned by Nuveen Asset Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Mastercard Incorporated Cl A (MA)
JPMorgan Chase & Co. (JPM)
Costco Wholesale Corporation (COST)
Nushares Etf Tr Get Opp Etf (NUGO)
Visa Com Cl A (V)

View all positions for Nuveen Asset Management

Top funds holding Regulus Therapeutics

Federated Investors
NEA Management Company
Octagon Capital Advisors
BlackRock
Vanguard Group
BlackRock
Deep Track Capital
T. Rowe Price Associates
Geode Capital Management
Alyeska Investment Group
State Street Corporation
Woodline Partners
DAFNA Capital Management
Point72 Asset Management
RA Capital Management

View all funds holding Regulus Therapeutics